Sagimet Biosciences Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
SGMT on Nasdaq
Industry
Pharmaceutical Preparations
Location
155 Bovet Rd., Suite 303, San Mateo, CA

There are no Buy or Sell transactions made by insiders since 11/19/2024

Sagimet Biosciences Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
NEA Partners 13, Limited Partnership 10%+ Owner $12.3M Jan 29, 2024
New Enterprise Associates 13 Lp 10%+ Owner $12.3M Jan 29, 2024
KPCB PBD Associates, LLC 10%+ Owner $7.79M Jul 18, 2023
Jinzi Jason Wu Director $6.78M Jul 18, 2023
David Happel President & CEO, Director $2.19M Jul 21, 2025
Elizabeth Rozek Chief Legal & Admin. Officer $1.33M Nov 4, 2025
George Kemble Director $376K Jun 9, 2025
Eduardo Bruno Martins Chief Medical Officer $340K Jul 21, 2025
Patrick J. Kerins 10%+ Owner $53.9K Jan 29, 2024
Thierry Chauche Chief Financial Officer $53.8K Feb 6, 2025
Merdad Parsey Director $52.5K Jun 5, 2024
Forest Baskett 10%+ Owner $46.3K Jan 29, 2024
Scott D. Sandell 10%+ Owner $28.7K Jan 29, 2024
Anthony M. Rimac Chief Operating Officer Jul 18, 2023
Dennis Hom Chief Financial Officer Jul 18, 2023
Elizabeth Grammer Director Jun 9, 2025
Richard J. Rodgers Director Jul 18, 2023
Jennifer Jarrett Director Jun 9, 2025
Beth C. Seidenberg Director Jun 6, 2025
Anne M. Phillips Director Jun 9, 2025
Timothy P. Walbert Director Jun 9, 2025
Paul W. Hoelscher Director Jun 9, 2025
Joseph Oriti Officer Title: Interim Principal Financial Officer. Exhibit 24 - Power of Attorney Feb 1, 2024

Recent Insider Transactions by Companies or Individuals for Sagimet Biosciences Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.